The Impact of Anemia on Long-Term Mortality in Hospitalized Patients with Exacerbation of Chronic Obstructive Pulmonary Disease

Eduardo Garcia-Pachon,Isabel Padilla-Navas

DOI: https://doi.org/10.2147/copd.s469627

2024-10-10

International Journal of COPD

Abstract:Eduardo Garcia-Pachon, Isabel Padilla-Navas Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain Correspondence: Eduardo Garcia-Pachon, Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, 03203, Spain, Email Purpose: Anemia is a risk factor for mortality within the general population and is notably prevalent among individuals with chronic obstructive pulmonary disease (COPD). Our objective was to investigate the impact of anemia on the long-term mortality risk of hospitalized COPD patients. Additionally, we aimed to identify the cause of mortality to assess whether it was different in relation to the presence of anemia. Patients and Methods: This was an observational retrospective analysis of prospectively collected data of consecutive patients admitted because of COPD exacerbation. Clinical characteristics, the presence of anemia, months of survival and cause of death if occurred, were recorded. Patients were categorized into two groups: anemic (for women hemoglobin level < 12 g/dL and for men hemoglobin level < 13 g/dL) and non-anemic. Survival analysis was conducted using Kaplan-Meier curves and Cox proportional hazard regression analysis. Results: A total of 125 patients (20% women) were included in the study. Among them, 31 (25%) were identified as anemic, By the conclusion of the study, 59 patients (47%) had died: 27 out of 31 anemic patients (87%) and 32 out of 94 non-anemic patients (34%) (p< 0.001). Anemia was a robust predictor of mortality one year after admission (adjusted hazard ratio HR; 5.20 [1.86– 14.55]); three years after admission (HR 4.30 [2.03– 9.10]), and at the study's termination (with a follow-up period ranging from a minimum of 38 months to a maximum of 56 months) (HR; 3.80 [1.96– 7.38]). Mortality in the group of patients with anemia was of 27 individuals (87%) and 32 (34%) in patients without anemia (p< 0.001). The causes of mortality in patients with or without anemia were similar. Conclusion: The detection of anemia upon admission for COPD exacerbation serves as a robust predictor of mortality in the subsequent years. Keywords: anemia, COPD, hospitalization, mortality, prognosis It is well-established that patients with Chronic Obstructive Pulmonary Disease (COPD) have a elevated risk of mortality compared to the general population, with severity of the disease at diagnosis correlating with this risk. 1 Exacerbations of COPD, in terms of both frequency and severity, have also been linked to heightened mortality rates in these patients. 1 A recent meta-analysis concluded that significant predictors of mortality in COPD include prior hospitalization, early readmissions, cardiovascular comorbidity, age, male sex, and the use of home oxygen therapy. 2 Various multifunctional indices have been developed to predict mortality in COPD patients; 3 however, the mortality prediction models developed thus far have only demonstrated moderate discriminative capability. 2 It is recognized that anemia represents a risk factor for mortality across the general population, irrespective of age, gender, or cardiovascular disease history, 4 and anemia is notably prevalent among individuals with COPD, with prevalence rates ranging from 5% to 38%. 5,6 However, despite its significance, this characteristic has not been incorporated into mortality prediction models for COPD. There is compelling evidence linking the presence of anemia to an elevated risk of mortality in patients with COPD. As early as 1973, Kilburn and Asmundsson 7 reported that anemia was associated with increased mortality in this disease. Low hemoglobin levels in stable-phase COPD patients are associated with increased healthcare resource utilization, worse quality of life, older age, male gender, and serves as a prognostic predictor for the risk of hospitalization, as well as early and long-term mortality. 5,8,9 Additionally, in patients hospitalized for COPD, the presence of anemia has been associated with adverse outcomes and an increased healthcare burden. 10 However, the mortality risk associated with anemia in patients hospitalized for COPD exacerbation has received scant attention. Existing studies have typically focused on specific time periods or patient characteristics. 11–13 Given that patients with COPD requiring hospital admission represent those with the highest mortality risk, exploring predictive variables in these patients holds particular significance. We aimed to analyze the impact of anemia on the mortality risk of consecutive COPD patients who required hospitalization due to exacerbation of their disease. Additionally, we aime -Abstract Truncated-

respiratory system